GLPwatch
Soliqua vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCSoliqua contains the active ingredient lixisenatide and is made by Sanofi, while Victoza contains liraglutide and is made by Novo Nordisk. Both are injected under the skin to treat type 2 diabetes, but Victoza is also FDA-approved to reduce cardiovascular risk. The main difference is their active ingredients and manufacturers.
AI summary of the sources below.
| Soliqua | Victoza | |
|---|---|---|
| Active ingredient | lixisenatide | liraglutide |
| Manufacturer | sanofi | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-03-18 | 2023-02-06 |